Dow Demonstrate Committment to Global Health at Worldwide Industry Exhibition

Dow is demonstrating its commitment to the global Health and Hygiene market segment with an expanded presence at INDEX 08 (Geneva, April 15-18). Held every three years, INDEX is one of the largest exhibitions for the nonwovens industry worldwide.

Dow's presence at INDEX will include a two-level stand (#1540) near the main entrance to Geneva’s Palexpo exhibition hall, where it will demonstrate its broad portfolio of plastic and performance chemicals for applications such as diapers, feminine hygiene products, adult incontinence products, medical garments, hospital disposables and wipes. In particular, Dow will advance its credentials as a developer of innovative technologies by showcasing the advanced performance of INFUSE™ Olefin Block Copolymers in nonwoven applications. As part of the product forums programme at INDEX, Dow experts will also deliver three technical presentations on INFUSE Olefin Block Copolymers.

“New and innovative nonwoven materials are needed to allow the development of consumer products with new features and advanced performance at improved cost-in-use,” said Jose Pina, Dow’s global marketing director for Health & Hygiene. “That is why we are so excited about INFUSE Olefin Block Copolymers, which are excellent positioned for use in extensible and elastic components, as well as in adhesive components, enabling advanced nonwoven products.”

Posted March 30th,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.